New CMAC research reveals that tablet strength loss at high production speeds is due to increased lubricant distribution from faster feedframe paddle rotation, not compression speed. Using Huxley Bertram’s HB50 simulator, the team isolated variables and replicated industrial conditions.

Shionogi, a leading Japanese pharmaceutical company, has joined the CMAC consortium, marking a pivotal step in global collaboration and innovation.

The CMAC Data Lab is entering a transformative era in drug development and manufacturing. As part of CMAC’s commitment to innovation and research excellence, we’ve integrated cutting-edge Knowledge Graph software from Plvs Ultra into our research facility.

Lonza has joined CMAC as a Translation to Industry Collaborator to enhance its service offering for specialty and enhanced drug product and particle technologies

A new £1m research project to realise the transformative potential of digital technologies like artificial intelligence (AI) in medicines development and manufacturing has been announced.

The Centre of Excellence in Regulatory Science and Innovation (CERSI) project aims to advance regulatory processes by integrating cutting-edge digital technologies.

CMAC has appointed John Mack as a new member of its Industry Board. Representing CMAC’s Tier 2 membership, John’s role will enhance the Tier 2 community's connection to CMAC’s activities, ensuring the centre stays at the forefront of manufacturing advancements and continues to meet the evolving needs of its members.

Weiling’s research primarily focuses on data management and analysis for 3D printable biomaterials. Her day-to-day tasks include debugging code, reading research papers, and leading regular online catch-ups with colleagues in Nottingham.

At DM2, we recognize the vital role of public trust in the integration of digital technologies in medicine manufacturing. Through our outreach efforts we engaged a local community, gathering insights and addressing concerns about AI and robotics in healthcare. By fostering open dialogue, we aim to shift perceptions, paving the way for a brighter future in medicine.

In his role at CMAC, Christoph is part of the analysis team, where he is responsible for keeping various instruments running and training others on their use. This is an important job, as analysis is a key component of every project, from industry initiatives to generating data for modelling.

In her current role as a Teaching Fellow, Natalie supports training and teaching within CMAC, particularly by contributing to the training curriculum for the new EPSRC-funded Centre for Doctoral Training in Cyber-Physical Systems for Medicine Manufacturing (CEDAR).

In the September edition of our 'Meet Our Team' series, we are delighted to celebrate Thomas McGlone, CMAC’s Senior Technical Operations Manager and Tier 2 Manager.

Global CDMO Ajinomoto Bio-Pharma Services has become the first organisation to position itself as a Translation to Industry Collaborator within CMAC, a world-leading centre for medicines manufacturing at the University of Strathclyde.

Together, CMAC and digiM will align to accelerate research and development within CMAC’s ambitious strategy for digital transformation of Chemistry, Manufacturing, and Control (CMC) processes.

As a PhD researcher in crystallisation, Mitchelle’s work focuses on digital design strategies for  industrial crystallisation. In this role, she evaluates active pharmaceutical ingredient properties and crystalliser hydrodynamics for process scale-up.

CMAC launches campaign encouraging postdoctoral researchers from around the globe, to apply for a prestigious Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship.

In the July edition of CMAC’s 'Meet Our Team' series, we are delighted to celebrate Mohammed Al Qaraghuli, Project and Industrial Translation Manager for CMAC’s DM² programme.

CMAC staff and students recently gathered at the Hilton Dunblane Hydro Hotel for CMAC’s annual Summer School, a week-long event featuring workshops, seminars, and networking opportunities.

Since joining CMAC in November 2022, Molly has become an integral part of the team. Her role includes a wide range of diverse and versatile responsibilities and tasks that showcase her adaptability and commitment to the team's success.

The EPSRC MediForge Hub will transform the development and manufacturing of medicines by pioneering an Industry 5.0 manufacturing system for sustainable, resilient, and human-centric medicine production.

In her current role as Project Scientist at CMAC, Carlota is the Theme Lead for Formulation/Drug Product at the National Facility, where she addresses formulation challenges.